4.1 Article

Investigating the association between common DRD2/ANKK1 genetic polymorphisms and schizophrenia: a meta-analysis

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability

Alejandra Koeneke et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

AWESOME: a database of SNPs that affect protein post-translational modifications

Yang Yang et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemistry & Molecular Biology

Effects of a GWAS-Supported Schizophrenia Variant in the DRD2 Locus on Disease Risk, Anhedonia, and Prefrontal Cortical Thickness

Margarita V. Alfimova et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

Frequency of ANKK1, DRD2, DRD3 gene polymorphisms in refractory schizophrenia patients

F. D. D. Nunes et al.

GENETICS AND MOLECULAR RESEARCH (2019)

Article Clinical Neurology

Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis

Hairong He et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)

Letter Genetics & Heredity

DRD2 Ser311Cys Polymorphism and Risk of Schizophrenia

Yuichiro Watanabe et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2015)

Article Biotechnology & Applied Microbiology

Association between ANKK1 (rs1800497) and LTA (rs909253) Genetic Variants and Risk of Schizophrenia

Arwa H. Arab et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Medicine, General & Internal

Schizophrenia

Rene S. Kahn et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Review Genetics & Heredity

Association Between DRD2 (rs1799732 and rs1801028) and ANKK1 (rs1800497) Polymorphisms and Schizophrenia: A Meta-Analysis

Jun Yao et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2015)

Article Genetics & Heredity

Identification of ANKK1 rs1800497 Variant in Schizophrenia: New Data and Meta-Analysis

Chen Zhang et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2014)

Article Neurosciences

Association study between the Taq1A (rs1800497) polymorphism and schizophrenia in a Brazilian sample

Quirino Cordeiro et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2014)

Article Multidisciplinary Sciences

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke et al.

NATURE (2014)

Article Medicine, Research & Experimental

Functional-141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population

Ling Xiao et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)

Article Behavioral Sciences

The genetic validation of heterogeneity in schizophrenia

Atsushi Tsutsumi et al.

BEHAVIORAL AND BRAIN FUNCTIONS (2011)

Article Biochemistry & Molecular Biology

Dopamine D2 receptor gene-141C Insertion/Deletion polymorphism in Turkish schizophrenic patients

Hulyam Kurt et al.

MOLECULAR BIOLOGY REPORTS (2011)

Review Pharmacology & Pharmacy

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Jean-Martin Beaulieu et al.

PHARMACOLOGICAL REVIEWS (2011)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Article Computer Science, Interdisciplinary Applications

Conducting Meta-Analyses in R with the metafor Package

Wolfgang Viechtbauer

JOURNAL OF STATISTICAL SOFTWARE (2010)

Review Clinical Neurology

A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes

Caroline Dubertret et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)

Article Pharmacology & Pharmacy

Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms

M. Gupta et al.

PHARMACOGENOMICS (2009)

Article Psychiatry

C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients

J. Hoenicka et al.

ACTA PSYCHIATRICA SCANDINAVICA (2006)

Article Psychology, Multidisciplinary

Assessing heterogeneity in meta-analysis:: Q statistic or I2 index?

Tania B. Huedo-Medina et al.

PSYCHOLOGICAL METHODS (2006)

Article Genetics & Heredity

The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia:: Evidence from fixed- and random-effects meta-analyses

SJ Glatt et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)

Article Neurosciences

Association of DRD2 gene variant with schizophrenia

R Kukreti et al.

NEUROSCIENCE LETTERS (2006)

Article Genetics & Heredity

DRD2-141C insertion/deletion polymorphism is not associated with schizophrenia: Results of a meta-analysis

SJ Glatt et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)

Article Genetics & Heredity

Dopamine D2 receptor gene Ser311Cys variant and schizophrenia:: Association study and meta-analysis

EG Jönsson et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)

Article Neurosciences

Delusional disorder: Molecular genetic evidence for dopamine psychosis

K Morimoto et al.

NEUROPSYCHOPHARMACOLOGY (2002)

Article Clinical Neurology

The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and-141C Ins/Del polymorphisms

A Himei et al.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2002)

Article Genetics & Heredity

Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia

H Hori et al.

AMERICAN JOURNAL OF MEDICAL GENETICS (2001)